Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. INSP
stocks logo

INSP

-
Add to WatchlistAdvanced Chart
$
0.000
0(0.000%)1D
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
214.49M
+9.5%
0.208
-35.06%
240.33M
+18.28%
0.599
-0.24%
292.87M
+22.17%
1.348
+17.18%
Estimates Revision
The market is revising Upward the revenue expectations for Inspire Medical Systems, Inc. (INSP) for FY2025, with the revenue forecasts being adjusted by 0.01% over the past three months. During the same period, the stock price has changed by -12.35%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.01%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+4.48%
In Past 3 Month
Stock Price
Go Down
down Image
-12.35%
In Past 3 Month
14 Analyst Rating
up Image0
Wall Street analysts forecast INSP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INSP is 215.83 USD with a low forecast of 174.00 USD and a high forecast of 270.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Buy
3 Hold
0 Sell
Strong Buy
up Image0
Current: 126.830
sliders
Low
174.00
Averages
215.83
High
270.00
up Image0
Current: 126.830
sliders
Low
174.00
Averages
215.83
High
270.00
Morgan Stanley
Overweight
downgrade
$200 -> $182
2025-07-15
New
Reason
Morgan Stanley
Price Target
$200 -> $182
2025-07-15
New
downgrade
Overweight
Reason
Morgan Stanley lowered the firm's price target on Inspire Medical to $182 from $200 and keeps an Overweight rating on the shares. The firm continues to like the MedTech industry setup into Q2 on relative stability in procedure volumes and hospital capital expenditures across the space, the analyst tells investors in a research note.
Leerink
Market Perform
downgrade
$176 -> $149
2025-07-14
Reason
Leerink
Price Target
$176 -> $149
2025-07-14
downgrade
Market Perform
Reason
Leerink lowered the firm's price target on Inspire Medical to $149 from $176 and keeps a Market Perform rating on the shares ahead of quarterly results. The firm is updating estimates to reflect financial statement disclosures and its updated views, and price targets of several names in the space to reflect recent changes in valuation premiums.
Keybanc
Tim Rezvan
Buy
Maintains
$234 → $216
2025-04-21
Reason
Keybanc
Tim Rezvan
Price Target
$234 → $216
2025-04-21
Maintains
Buy
Reason
KeyBanc lowered the firm's price target on Inspire Medical to $216 from $234 and keeps an Overweight rating on the shares. The firm believes underlying MedTech trends remain mostly positive heading into Q1 earnings season, but is lowering several price targets to reflect macro concerns around the potential impact of tariffs as well as an increased risk of recession.
Stifel
Jonathan Block
Hold
Maintains
$190 → $175
2025-04-21
Reason
Stifel
Jonathan Block
Price Target
$190 → $175
2025-04-21
Maintains
Hold
Reason
RBC Capital
Shagun Singh
Buy
Maintains
$260 → $215
2025-04-15
Reason
RBC Capital
Shagun Singh
Price Target
$260 → $215
2025-04-15
Maintains
Buy
Reason
RBC Capital analyst Shagun Singh lowered the firm's price target on Inspire Medical to $215 from $260 and keeps an Outperform rating on the shares as part of a broader research note previewing Q1 results for Medical Devices. Q1 underlying procedure volume and capital placements trends were solid with typical seasonality at play, which should position companies under coverage to beat expectations for the quarter, while FX has moved notably to favor large-cap medical device companies with international exposure, which is not factored into consensus estimates for Q1 or 2025, the analyst tells investors in a research note. Tariff impact is likely to be clarified by several companies, though many companies under coverage have low tariff exposure with a substantial U.S. manufacturing footprint or low relative exposure vs. other large caps, the firm adds.
Morgan Stanley
Kallum Titchmarsh
Buy
Maintains
$230 → $220
2025-02-11
Reason
Morgan Stanley
Kallum Titchmarsh
Price Target
$230 → $220
2025-02-11
Maintains
Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Inspire Medical Systems Inc (INSP.N) is 50.00, compared to its 5-year average forward P/E of -5.81. For a more detailed relative valuation and DCF analysis to assess Inspire Medical Systems Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-5.81
Current PE
50.00
Overvalued PE
215.58
Undervalued PE
-227.20

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-37.09
Current EV/EBITDA
16.58
Overvalued EV/EBITDA
134.94
Undervalued EV/EBITDA
-209.13

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PS
14.10
Current PS
3.84
Overvalued PS
21.98
Undervalued PS
6.22

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

INSP News & Events

Events Timeline

(ET)
2025-05-06
09:48:56
Inspire Medical falls -11.9%
select
2025-05-05 (ET)
2025-05-05
17:17:05
Inspire Medical raises FY25 EPS view to $2.20-$2.30 from $2.10-$2.20
select
2025-05-05
17:15:25
Inspire Medical reports Q1 EPS 10c, consensus (23c)
select
Sign Up For More Events
Sign Up For More Events

News

Preview
6.5
06-05NASDAQ.COM
Analysts Forecast 19% Gains Ahead For The Holdings of RWJ
  • ETF Analysis: The Invesco S&P SmallCap 600 Revenue ETF (RWJ) has an implied analyst target price of $49.28, indicating an 18.84% upside from its current trading price of $41.47, with notable upside potential in holdings like PRA Group Inc, Crescent Energy Co, and Inspire Medical Systems Inc.

  • Analyst Target Justification: Questions arise regarding the validity of analysts' target prices, as high targets may reflect optimism but could also lead to downgrades if they are based on outdated information or fail to account for recent developments in the companies and industries involved.

Preview
1.0
05-30Newsfilter
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight
  • Inspire Medical Systems Presentation: Inspire Medical Systems will participate in the Wells Fargo 2025 MedTech Innovation Spotlight on June 13, 2025, with a presentation scheduled for 12:00 p.m. Eastern Time, accessible via live webcast.

  • Company Overview: Inspire focuses on developing minimally invasive solutions for obstructive sleep apnea and offers the first FDA-approved neurostimulation technology for treating moderate to severe cases of the condition.

Preview
6.0
05-06Benzinga
Morgan Stanley Maintains Overweight on Inspire Medical Systems, Lowers Price Target to $200
  • Real-time Intelligence for Traders: Benzinga Pro offers the fastest news alerts and exclusive stories to help traders make informed decisions in the stock market.

  • Community of Serious Traders: Over 10,000 traders are part of the Benzinga Pro community, benefiting from accurate market intelligence and insights.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Inspire Medical Systems Inc (INSP) stock price today?

The current price of INSP is 126.83 USD — it has decreased -0.89 % in the last trading day.

arrow icon

What is Inspire Medical Systems Inc (INSP)'s business?

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.

arrow icon

What is the price predicton of INSP Stock?

Wall Street analysts forecast INSP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INSP is 215.83 USD with a low forecast of 174.00 USD and a high forecast of 270.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Inspire Medical Systems Inc (INSP)'s revenue for the last quarter?

Inspire Medical Systems Inc revenue for the last quarter amounts to 201.32M USD, increased 22.75 % YoY.

arrow icon

What is Inspire Medical Systems Inc (INSP)'s earnings per share (EPS) for the last quarter?

Inspire Medical Systems Inc. EPS for the last quarter amounts to 0.10 USD, decreased -129.41 % YoY.

arrow icon

What changes have occurred in the market's expectations for Inspire Medical Systems Inc (INSP)'s fundamentals?

The market is revising Upward the revenue expectations for Inspire Medical Systems, Inc. (INSP) for FY2025, with the revenue forecasts being adjusted by 0.01% over the past three months. During the same period, the stock price has changed by -12.35%.
arrow icon

How many employees does Inspire Medical Systems Inc (INSP). have?

Inspire Medical Systems Inc (INSP) has 1246 emplpoyees as of July 20 2025.

arrow icon

What is Inspire Medical Systems Inc (INSP) market cap?

Today INSP has the market capitalization of 3.74B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free